关键数据
0.953今开
0.989最高
21.99K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.45%换手率
0.940昨收
0.906最低
21.32K成交额
亏损市盈率静
0.37市净率
0.00%股息率 TTM
-128.83%ROA
13.54052周最高
0.14量比
-37.64M净利润
4.88M总股本
-1054.6482每股收益TTM
2.91Beta
-154.38%ROE
0.90652周最低
8.83%振幅
-123.13%毛利率
4.73M总市值
-3.25回报/风险
202.88%风险率

即将为您带来更多新闻,敬请期待。。。
Co-Diagnostics Inc评分
0.01与上次评分对比预测8.00
财务诊断5.99
技术分析4.99
公司估值1.00
机构认同度3.00
风险评估1.71
分析师评级
Co-Diagnostics Inc 最新财报电话会记录
科迪亚诊断 (CODX) 2026年第二季度业绩电话会议:现金减少之际FDA申报取得进展
Co-Diagnostics 2026财年第二季度营收达到16.6万美元,亏损有所收窄;同时,CODX已向FDA提交了其流感和RSV检测产品的申请,期末持有现金360万美元。
财务指标
货币: USD

由于公司未披露,未能获取相关数据
货币: USD

由于公司未披露,未能获取相关数据
Co-Diagnostics Inc 简介
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
行业医疗设备与耗材
公司代码CODX
员工数量132
国家United States of America
持股情况
| 持股股东 | 占比 |
|---|
| Orca Capital GmbH | 1.74% |
|---|
| Private Advisory Group LLC | 1.15% |
|---|
| Egan (Dwight H.) | 0.82% |
|---|
| Renaissance Technologies LLC | 0.68% |
|---|
| 股东类型 | 占比 |
|---|
| Investment Advisor | 3.59% |
|---|
| Individual Investor | 3.39% |
|---|
| Hedge Fund | 0.72% |
|---|
| Investment Advisor/Hedge Fund | 0.56% |
|---|
常见问题
Co-Diagnostics Inc(CODX)的当前股价是多少?
Co-Diagnostics Inc(CODX)的当前股价是 0.94。
Co-Diagnostics Inc的股票代码是什么?
Co-Diagnostics Inc的股票代码是CODX。
Co-Diagnostics Inc股票的52周最高点是多少?
Co-Diagnostics Inc股票的52周最高点是13.54。
Co-Diagnostics Inc股票的52周最低点是多少?
Co-Diagnostics Inc股票的52周最低点是4.98。
Co-Diagnostics Inc的市值是多少?
Co-Diagnostics Inc的市值是4.61M。
现在Co-Diagnostics Inc(CODX)的股票是买入、持有还是卖出?
根据分析师评级,Co-Diagnostics Inc(CODX)的总体评级为买入,目标价格为4.00。
Co-Diagnostics Inc(CODX)股票的每股收益(EPS TTM)是多少
Co-Diagnostics Inc(CODX)股票的每股收益(EPS TTM)是-1054.65。